This post is from a suggested group
The Exponential Growth of the Gene Vector Market Driven by Gene Therapy
Description The Gene Vector Market is set for robust expansion, acting as the critical delivery mechanism for revolutionary gene therapies and vaccines that target a wide spectrum of diseases, from rare disorders to cancer.
The Gene Vector Market is poised for exponential growth, projected to increase from $1.64 billion in 2024 to $7.86 billion by 2035, with a substantial CAGR of 15.31%. This rapid expansion is primarily fueled by the rising global prevalence of genetic disorders and the increasing clinical adoption of gene therapy as a curative treatment. Government initiatives and significant public and private investment in gene therapy research further accelerate the development and commercialization of new vector technologies.
Gene vectors, which are the delivery vehicles for therapeutic genetic material, are highly segmented by type, including Viral Vectors (such as Adeno-Associated Virus, or AAV), Non-viral Vectors, Exosomes, and…